
India’s cheap weight-loss drugs could reshape global obesity fight
India could soon get a lot thinner – at least in theory.On Friday the patent on semaglutide – the molecule behind Danish drugmaker Novo Nordisk’s

India could soon get a lot thinner – at least in theory.On Friday the patent on semaglutide – the molecule behind Danish drugmaker Novo Nordisk’s

India is likely to see an increase in cotton acreage by up to a fifth in the upcoming 2026 kharif season, supported by a rebound

Maize serves as a vital model species for advancing our understanding of plant biology, yet many mysteries remain about the intricate processes governing how DNA

Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies. Hetero has launched its generic semaglutide portfolio in

Ultra-low dose of cancer meds works, reduces costs by 90%, finds Tata studyThe Parel-based premier cancer hospital found that giving one-tenth of the standard dosage

The eagerly anticipated semaglutide patent cliff in India has unleashed a strikingly varied pricing landscape. The intensity of the price decline is driven by the
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump